Naama is combining systems-biology with microbiology and immunology to study the interactions between gut microbes and the host immune system in health and disease. She has characterized the host response to a variety of gut microbes and has applied a metabolic labeling approach to fluorescently label the anaerobic gut microbes. In addition, she is studying microbial genetic mechanisms that allow gut microbes to thrive the dynamic gut ecosystem and to co-op with bacteriophage. She is a recipient of the Alon Fellowship, the national and international UNESCO-L’Oreal award, the Human Frontiers fellowship, the EMBO fellowship, the John F. Kennedy Prize, the Teva Prize, and the Barenholz prize, for academic excellence. Naama received her B.Sc. from Tel Aviv University, double-majoring in Chemistry and Biology, with summa cum laude honors. Her M.Sc. and Ph.D., are from the Weizmann Institute, studying systems-biology of protein dynamics in cancer, with Prof. Uri Alon, completed with honors. Her postdoctoral training was at Harvard Medical School, studying gut microbiota-host interactions with Prof. Dennis Kasper.